SATB1 and neoplasm: Notably, tumor-infiltrating CD8+ T cells from SATB1-CAR-T group exhibited 50% lower PD-1, CTLA-4, TIM3, and LAG-3 expression compared to controls (Fig. S6), aligning with their exhaustion-resistant phenotype in vitro.